Knowles (KN) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 revenue increased 18.3% year-over-year to $204.7M, driven by the Cornell Dubilier acquisition and higher demand in key markets, meeting guidance and reflecting strong operational execution.
Non-GAAP diluted EPS was $0.24, up from $0.23 in Q2 2023, in line with expectations.
Net cash from operations was $24.9M, supporting share repurchases and debt reduction.
A $249.4M goodwill impairment charge in Consumer MEMS Microphones led to a GAAP net loss of $259.3M for the quarter.
The company continues to review strategic alternatives for the CMM business, including a potential sale or restructuring.
Financial highlights
Adjusted EBIT for Q2 2024 was $29.5M (14.4% margin), up from $27.7M in Q2 2023; adjusted EBITDA was $37.2M (18.2% margin).
Gross profit for Q2 2024 was $77.6M (37.9% margin); non-GAAP gross margin was 38.9%.
Net loss of $259.3M in Q2 2024, primarily due to a $249.4M goodwill impairment.
Interest expense increased to $4.6M in Q2 2024, mainly due to the Cornell Dubilier acquisition financing.
Six-month 2024 revenues were $401.1M, up from $317.3M in the prior year period.
Outlook and guidance
Q3 2024 revenue expected between $210M and $220M, with non-GAAP EPS guidance of $0.29–$0.33 and GAAP EPS of $0.20–$0.24.
Net cash from operating activities projected at $35M–$45M for Q3 2024.
Capital expenditures for 2024 are projected at 2.0% to 3.0% of revenues.
Management expects continued growth in MedTech, Specialty Audio, and Precision Devices segments.
Management expects to reduce cash balances in the second half of 2024, primarily due to Seller Note payment and debt reduction.
Latest events from Knowles
- Annual meeting covers director elections, executive pay, and auditor ratification for 2026.KN
Proxy Filing11 Mar 2026 - 2026 proxy covers director elections, executive pay, auditor ratification, and robust governance.KN
Proxy Filing11 Mar 2026 - Clean energy and climate/sustainability drive growth as portfolio streamlining boosts margins.KN
Barclays 43rd Annual Industrial Select Conference17 Feb 2026 - Q4 2025 revenue and EPS surged, capping a successful transformation and strong 2026 outlook.KN
Q4 20255 Feb 2026 - Portfolio shift to MedTech, defense, and industrial boosts margins and growth outlook.KN
2024 Southwest IDEAS Conference3 Feb 2026 - Targets 8–10% annual revenue growth and 10–14% EBITDA growth through organic and M&A strategies.KN
Investor Day 20253 Feb 2026 - Q3 revenue up 32% year-over-year; strategic divestiture and margin gains position for growth.KN
Q3 202418 Jan 2026 - Q1 2025 revenue hit $132.2M, with strong cash flow and robust Precision Devices demand.KN
Q1 202526 Dec 2025 - 2024 revenue up 21% and non-GAAP EPS up 32%, with strong cash flow and major new orders.KN
Q4 202423 Dec 2025